Washington — Legislation recently introduced in the Senate would provide $1 billion in mandatory funding per year for 10 years to the National Institutes of Health to support research on long COVID-19.

Albany, NY — People who continue to experience COVID-19 symptoms at least three months after contracting the virus have what’s known as “long COVID.”

Robots and cobots can help when your food or beverage has workers out sick with COVID-19 or needs to implement social distancing.

When I was an electrical engineer building emergency wireless communications networks, I learned about the importance of having backups—sometimes the hard way, with a 3 a.m. phone call reporting a system is down and the backup system didn’t kick in.

We've all had our lives turned upside down by the COVID-19 pandemic, and that's going to continue for at least a little while longer.

Children's Geographies; 10/01/2021
(AN 152966703); ISSN: 14733285
Academic Search Premier

Children's Geographies; 08/01/2022
(AN 158427722); ISSN: 14733285
Academic Search Premier

Children's Geographies; 08/01/2022
(AN 158427720); ISSN: 14733285
Academic Search Premier

Children's Geographies; 08/01/2022
(AN 158427719); ISSN: 14733285
Academic Search Premier

Children's Geographies; 08/01/2022
(AN 158427718); ISSN: 14733285
Academic Search Premier

Children's Geographies; 08/01/2022
(AN 158427717); ISSN: 14733285
Academic Search Premier

Children's Geographies; 08/01/2022
(AN 158427723); ISSN: 14733285
Academic Search Premier

Children's Geographies; 08/01/2022
(AN 158427724); ISSN: 14733285
Academic Search Premier

Children's Geographies; 04/01/2023
(AN 163915527); ISSN: 14733285
Academic Search Premier

Children's Geographies; 04/01/2023
(AN 163915525); ISSN: 14733285
Academic Search Premier

Children's Geographies; 08/01/2023
(AN 167303413); ISSN: 14733285
Academic Search Premier

Children's Geographies; 02/01/2024
(AN 175911755); ISSN: 14733285
Academic Search Premier

Children's Geographies; 02/01/2024
(AN 175911764); ISSN: 14733285
Academic Search Premier

Children's Geographies; 02/01/2024
(AN 175911763); ISSN: 14733285
Academic Search Premier

Children's Geographies; 02/01/2024
(AN 175911757); ISSN: 14733285
Academic Search Premier

Children's Geographies; 04/01/2024
(AN 178088139); ISSN: 14733285
Academic Search Premier

Children's Geographies; 06/21/2024
(AN 178113385); ISSN: 14733285
Academic Search Premier

Children's Geographies; 08/01/2024
(AN 178911405); ISSN: 14733285
Academic Search Premier

The post Estimation of the prevalence of anxiety during the COVID-19 pandemic: A meta-analysis of meta-analyses was curated by information for practice.

Four Statements Christians Really Need to Rethink Pastors are making huge decisions this week, the choice to resume worship as normal, or wait a little longer… or somewhere in between. This means filtering through all the “spin” that everyone is spewing right now. This post has no spin. I have no political or religious agenda. …

Continue reading "THE STUPID STUFF WE SAY ABOUT COVID-19"

The post THE STUPID STUFF WE SAY ABOUT COVID-19 appeared first on Jonathan's Blog From The Source.

The post How much does long COVID cost individuals, informal carers, and society? was curated by information for practice.

The post Patterns of depression symptoms in relation to stressors and social behaviors during the COVID-19 pandemic among older youth and emerging adults in the United States was curated by information for practice.

We talk about what you need to know about the importance and safety of the COVID-10 vaccine in children, and the status and process of vaccination approval for children under twelve. Also, how to navigate summer activities, travel, and masks with unvaccinated children, and the impacts of the virus on kids.

State leaders say they have a new plan to fight COVID-19 in nursing homes.

Trying to make nursing home safer from COVID-19

Six months after Gov. Tim Walz first declared the peacetime emergency, where is Minnesota in the response to the pandemic and what will the next few months bring? On this week’s Politics Friday, MPR News host Mike Mulcahy talked with Walz, discussing some of the pressing issues in Minnesota and taking listener questions from around the state. 

Sen. Tina Smith and her Republican challenger Jason Lewis sparred over the coronavirus response, public safety, climate change and immigration Friday during a debate on MPR News. 

Our new climate change reporting initiative, By Degrees , begins in an unprecedented time – one where people are making seismic shifts in their lifestyles and attitudes in response to COVID-19 and the Black Lives Matter movement. Many of our listeners have wondered: why haven’t people reacted the same way to the climate emergency, and could that be about to change?

COVID-19 has been hard on just about every industry in New Hampshire, and renewable energy is no exception. People worried about money are putting off investing in solar panels, and health concerns have made home energy efficiency visits more complicated. But scientists say investments like these can lower energy costs, and remain a critical way to combat the other big crisis we’re facing – climate change. As part of NHPR’s new climate change reporting project, By Degrees , NHPR’s Annie Ropeik has been trying to find out what might be ahead for the renewable energy industry in the state. Morning Edition Host Rick Ganley spoke with her about what’s next.

The new coronavirus SARS-CoV-2, which causes atypical pneumonia COVID-19, can also penetrate into the brain, disrupt the work of the nervous system and cause other severe complications. The disease may not be limited to respiratory infections only. As practical studies show, in a significant number of patients, the virus affects the nervous system. The mechanism of its impact on nerve cells has not been studied yet, but scientists believe that there is some connection: a temporary loss of taste or smell was recognized as specific symptoms of COVID-19 in the middle of March. To make matters worse, the virus may penetrate directly into the brain from the nasopharynx. In this case, the virus may trigger a series of complications, disrupting the normal functioning of almost any organ. The list of possible concomitant diseases is extensive:

Back to normal. Back to a spike in cases, hospitalizations and deaths. Politics before the People, it’s the economy, stupid! The UK heads for Hades. In the midst of this latest global pandemic, common sense seems to have flown out of the window, however incredible it may seem given all the collective knowledge we have gathered over the years. If we look at the history book, we are practically where we were one century ago with so-called Infuenza A H1N1 (Spanish Flu, which was not from Spain but from the USA) and if we turn back just one page, we see that we are back where we were at this time last year. We are going round and round in circles because policymakers are failing us. Common sense, not conspiracy theories Talking about common sense, forget all the conspiracy theories that this is a master plan to cull those members of society more dependent on the State, such as pensioners. It just so happens that their defences are weaker and so they are more susceptible to the illness. Forget the theories about injecting micro-chips with the vaccine. It just so happens that this is one of the main means we have to control the spread of the virus, not the only one but an important one. Forget the denial theories which say the disease does not exist. Go ask the families of those who have died from it. Mine included.

The trend of purchasing refurbished IT equipment is on the rise among MSPs. A significant majority of 84% have admitted to buying refurbished technology in the past, while about 30% are currently making such purchases.

Screenshot from the site of Japanese company K.K. Mirai Genomics The Moscow Healthcare Department purchased more than 50 devices and hundred of thousands of test systems for SARS-CoV-2 coronavirus from a company called Medpromresurs. This sounds like good news, if it was not for the dodgy reputation of the company. Thieving businessmen are trying to cash in on the disease that their compatriots suffer from while keeping an eye on the funds from the state budget too. US funded Radio Liberty investigated the Moscow's purchase, that got links to 2019 scandal in Tatarstan. The story began in September 2019. During the Eastern Economic Forum, which was held last autumn, a little-known Japanese company K.K. Mirai Genomics promised to invest 2.5 billion rubles ($30 million) in the production of a diagnostic system for infectious diseases in the Republic of Tatarstan. The systems were supposed to be subsequently acquired at the expense of mandatory medical insurance - the state budget that is. Russian company PharmMedPolis-RT acted as a partner on the Russian side. Taliya Minullina, the head of the Agency for Investment Development of the Republic, put her signature on the agreement for the production of biochips for the diagnosis of influenza. The story was highlighted by a lot of Russian media for its connection to corruption and money-laundering issues. The chips were allegedly patented in Europe, the USA and Japan (coronavirus was nowhere near back then). Strangely enough, the supposedly patented trademark for the LifeRing molecular diagnostic system that consists of disposable chips is not manufactured in any of the above-mentioned countries. Moreover, as the Versia found out, the company's offices in Japan and the United States are located in cheap Class B office buildings, which does not go along with the promise to invest 2.5 billion, because a company like that simply does not have that much money.  However, methods for rapid diagnosis of influenza are not just being developed in our country - they are already in practical use. Moreover, the time that is required for testing biomaterial is even shorter in comparison with the time period that foreign-made chips need for the same purpose.  K.K. Mirai Genomics was a very little-known company indeed: it did not even have a website at the time when the deal was signed. Mirai never provided any specifications and descriptions of the technology, nor did it say anything about the results of clinical trials. Such facts did not stop the authorities of Tatarstan, though. 

Moscow is dealing with an explosive increase in the number of COVID-19 cases, Moscow Mayor Sergei Sobyanin said, Interfax reports. According to him, the admission of seriously ill coronavirus patients to hospitals has increased by 70 percent. “Today we are on the rise, and a very big one. It is higher than, say, in April-May of the previous  year, when we first encountered this, and has almost reached the December peak, which was reported late last year," Sobyanin said during a visit to the coronavirus hospital at City Clinical Hospital No. 15 named after Filatov.

In Russia, as many as 986 people died of COVID-19 over the past 24 hours. This is a new record for Russia since the start of the pandemic, the operational headquarters for the fight against the coronavirus infection said on October 14. A day earlier, on October 13, 984 deaths were reported in Russia. The total death toll since the start of the pandemic thus amounts to 220,315 people.  Over the past 24 hours, 31,299 new cases of coronavirus infection were registered in the Russian Federation. This is the largest number of COVID-19 cases since the beginning of the pandemic. The total number of positive cases during the COVID-19 pandemic in Russia has thus amounted to 7.892,980. A day earlier (October 13) 28,717 cases of the coronavirus infection were recorded in the country.

Centrers for Disease Control and Prevention suggest that the more contagious subvariant BA.2 of omicron strain now makes up 72% of COVID-19 infections in the U.S. According to the data, the BA.2 is able to displace all other COVID-19 strains and its subvariants. Ali Mokdad, an epidemiologist at the Institute for Health Metrics and Evaluation in Washington state, estimates that the displacement might happen in the next two weeks. According to different sources, the BA.2 is from 30% to 80% more contagious than the BA.1. A top WHO official, Maria Van Kerkhove, describes BA.2 as the most transmissible version of the virus so far. 

An American from California simultaneously contracted the coronavirus and monkeypox, reports NBC. Mitcho Thompson, from the town of Sebastopol, told the TV channel that he tested positive for COVID-19 at the end of June, and soon after noticed red spots on his back, legs, arms and neck. "The doctor was absolutely certain that I had monkeypox and that I had both," Thompson said.

The Indian film industry has emerged stronger post COVID-19 with a new focus on modern filmmaking techniques and distribution models, according to experts from the University of South Australia and the University of Adelaide.

A teen gets a dose of Pfizer's COVID-19 vaccine at Holtz Children's Hospital in Miami on May 18. Nearly 7 million U.S. teens and pre-teens (ages 12 through 17) have received at least one dose of a COVID-19 vaccine, so far, the CDC says.; Credit: Eva Marie Uzcategui/Bloomberg via Getty Images

It's been a little more than a month since adolescents as young as 12 became eligible in the United States to receive the Pfizer vaccine against COVID-19, and nearly all reports have been positive: The vaccine is very effective in this age group, and the vast majority of kids experience mild side effects, if any — the same sore arm or mild flu-like symptoms seen among adults who get the shot.

The Centers for Disease Control and Prevention has recommended that everyone 12-years-old and older get vaccinated against COVID-19, and the rollout is well underway: According to the CDC, nearly 7 million U.S. teens and pre-teens (ages 12 through 17) have received at least one dose of a COVID-19 vaccine, so far.

Still, soon after the FDA authorized the use of Pfizer's vaccine in young people, federal agencies began receiving reports of mild chest pain or other signs of possible heart inflammation (known as myocarditis) in a very small percentage of recently vaccinated teens.

CDC director Rochelle Walensky said at a White House briefing Friday that there have been more than 300 cases of heart inflammation reported among more than 20 million teens and young adults who have received one of the vaccines made by Moderna or Pfizer. She said that in the "vast majority" of cases, the inflammation went away.

An expert advisory committee to the health agency is expected to review the cases in more depth at a meeting Friday.

So, in the meantime, should parents of teens hesitate to have their kids vaccinated against COVID-19? Vaccine experts and the American Academy of Pediatrics say no, don't hesitate. It's good for doctors and patients to be aware that there might be a connection between the mRNA vaccines and heart inflammation, and to report to their pediatrician anything they see in that first week after vaccination. But it is also important, the CDC notes, to recognize that even if this does turn out to be an extremely rare side effect of the vaccine, "most patients who received care responded well to medicine and rest and quickly felt better." And the serious risks of COVID -19 — even for young healthy people — outweigh the risks of any possible side effects from the vaccine. Here are some questions you may have, and what's known:

What exactly is myocarditis?

Myocarditis is an inflammation of the heart muscle, and pericarditis, also being investigated, is an inflammation of the sac around the heart.

Long before the pandemic, thousands of cases of myocarditis were diagnosed in the U.S. and around the world each year, often triggered by the body's immune response to infections. SARS-CoV-2 can trigger it, and so can cold viruses, and staph and strep and HIV. Other causes include toxins and allergies.

Symptoms include chest pain and shortness of breath. It's often mild enough to go unnoticed, but a full-blown case in adults can cause arrhythmias and heart failure that require careful treatment with multiple medications, and several months of strict rest. In a case study of seven teenagers who got myocarditis following vaccination published last week in the journal Pediatrics, all seven got better after routine treatment with anti-inflammatory drugs.

Pediatric cardiologist Dr. Stuart Berger of the Northwestern University Feinberg School of Medicine, a spokesperson for the American Academy of Pediatrics, says vaccine-related myocarditis in teens is not all that worrisome. "Although they appear with some symptoms of chest pain, and maybe some findings on EKGs, all of the cases we've seen have been on the mild end of the spectrum," he says.

So, what's the concern?

Several hundred reports about the inflammation have been filed with the federal government's Vaccine Adverse Event Reporting System (VAERS); that's a repository of reports sent in by health professionals and patients about any health events they spot in the hours or days after vaccinations. Many of the events reported turn out to be coincidental — not caused by a vaccine. The database is just meant as a starting point for further investigation and not proof of cause and effect. But as NPR's Geoff Brumfiel noted this week, "when millions of people are vaccinated within a short period, the total number of these reported events can look big."

That said, anecdotes reported by doctors in medical journals and reports to VAERS suggest that both of the mRNA vaccines authorized for use in the U.S. — the Pfizer and Moderna vaccines — might slightly increase the incidence of myocarditis in young people. In 2003, a report in the New England Journal of Medicine estimated the background incidence of myocarditis to be 1.13 cases in 100,000 children per year.

Paul Offit, professor of pediatrics at the Children's Hospital of Philadelphia and a member of a Food and Drug Administration vaccine advisory committee says there likely is a causal link between the heart inflammation some doctors are seeing in these teens and the second dose of vaccine. "I think it's real," he says, but hastens to add that the effect is exceedingly small – based on the data collected so far, maybe one in 50,000 vaccinees between the ages of 16 and 39. "And the good news is at least so far it looks to be transient and self-resolving."

Still, maybe I should wait to get my teen vaccinated and see how this plays out?

Uhm, no, according to several vaccine experts contacted by NPR. And this is where a little math comes in handy.

"Take a stadium full of 100,000 people between the ages of 16 and 39, which is the subset that appears to be at greater risk," Offit says. "Vaccinate all of them, and two might get myocarditis." But if you don't vaccinate any of the 100,000, he estimates that about 1,300 would eventually get COVID-19. And those numbers are likely to increase this winter.

About one in 1,000 children who get COVID-19 have gone on to develop a condition called MIS-C (multisystem inflammatory syndrome in children), says Offit, and most of those kids have had some level of myocarditis. In addition, the new coronavirus has directly caused myocarditis in some children and adults. Which of the two stadiums in Offit's metaphor would have more cases of myocarditis — the vaccinated children or unvaccinated kids — is not known precisely. But Offit says he suspects it would be the unvaccinated group. And there's no doubt that 1,000 unvaccinated children would suffer more COVID-19-related illnesses. "A choice not to get a vaccine is not a choice to avoid myocarditis," he says. "It's a choice to take a different risk — and I would argue a more serious one" — of developing a bad case of COVID-19 or long-COVID or COVID-caused myocarditis.

Are the experts advising their own kids in this age group to get vaccinated?

Yes. "I understand people having concerns," says Dr. Judith Guzman-Cottrill. She's a parent and professor of pediatric infectious diseases at the Oregon Health and Science University, as well as the senior author on a small study that came out this month in the journal Pediatrics. In the report, Guzman-Cottrill and her colleagues analyzed the cases of seven boys around the country who developed myocarditis within four days of receiving the Pfizer-BioNTech vaccine.

She and her family recently faced the vaccination decision for her own 13-year-old daughter — and said a whole-hearted yes to the shot.

Guzman-Cottrill suspects there may turn out to be a slightly increased risk of heart inflammation from vaccination in young people, but she and her co-authors note in the Pediatrics report that a direct cause-and-effect connection — even in these seven cases — has yet to be established. And she's impressed that despite the millions of doses that have so far been delivered to teens, no clear and serious post-vaccination problems have shown up. "The emergency departments and urgent care clinics are not filled with teenagers complaining of chest pain," she says.

She's treated unvaccinated teens who developed severe myocarditis from an infection with the COVID-19 virus, and others who developed COVID-19 pneumonia and respiratory failure. Seeing those teens struggle — teens who lacked the powerful immune protection the vaccine provides — was enough for her to suggest vaccination to her daughter, who got her second vaccination earlier this week.

"She saw it as a pathway back to a normal post pandemic life," Guzman-Cottrill says.

And that's where public health comes in. "We really need a highly vaccinated student body when kids return to the classroom this fall," says Guzman-Cottrill, "so we don't see surges in COVID-19 cases."

Joanne Silberner, a former health policy correspondent for NPR, is a freelance journalist living in Seattle.

This content is from Southern California Public Radio. View the original story at SCPR.org.

Facemasks remain worn as firefighter paramedic Jorge Miranda, holding syringe, speaks with Eduardo Vasquez, who has lived homeless on the streets of Los Angeles since 1992, before administering the one-shot Johnson and Johnson' Janssen Covid-19 vaccine as part of outreach to the homeless by members of the Los Angeles Fire Department's Covid Outreach unit on June 14, 2021 in Los Angeles.; Credit: FREDERIC J. BROWN/AFP via Getty Images

In our continuing series looking at the latest medical research and news on COVID-19, Larry Mantle speaks with UCSF’s Dr. Peter Chin-Hong. 

Topics today include:

• Two weeks after reopening, LA County’s new COVID-19 cases have doubled

• CDC: Infected vaccinated people carry less COVID-19 virus

• Delta variant is now detected in all 50 states

• J&J: “At present, there is no evidence to suggest need for a booster dose to be administered”

• Novavax claims vaccine’s overall efficacy is 89.7%

• Another respiratory virus is spreading in the U.S.

• Curevac’s final trial show shot is far less effective than other vaccines

• Can we now live with the coronavirus?

• Israel scrambles to curb rising COVID-19 infection rates

• Is it time to rethink “one-size-fits-all” approach for masking?

Guest:

Peter Chin-Hong, M.D., infectious disease specialist and professor of medicine at the UCSF Medical Center; he tweets @PCH_SF

This content is from Southern California Public Radio. View the original story at SCPR.org.

Detail of boxes with the U.S. donated Johnson & Johnson vaccine against Covid-19 at Universidad de Baja California on June 17, 2021 in Tijuana, Baja California. ; Credit: Francisco Vega/Getty Images

In our continuing series looking at the latest medical research and news on COVID-19, Larry Mantle speaks with Dr. Annabelle De St. Maurice from University of California Los Angeles/Mattel Children’s hospital.

Topics today include:

• J&J says its vaccine is effective against Delta variant

  • J&J vaccine lasts at least 8 months

• WHO says all vaccines it authorized should be recognized by reopening countries

• White House says it will miss July 4 vaccination goal

• Postpartum depression on the rise during the pandemic

• Experts believe Novavax may play a role in combating vaccine hesitancy

• Delta variant is not driving a surge in hospitalization rates in England

Guest: 

Annabelle De St. Maurice, M.D., assistant professor of pediatrics in the division of infectious diseases and the co-chief infection prevention officer at University of California Los Angeles/Mattel Children’s hospital; she tweets @destmauricemd

This content is from Southern California Public Radio. View the original story at SCPR.org.

A passenger wearing a protective face covering to combat the spread of the coronavirus, checks her phone while travelling on a bus along Oxford Street in central London on July 5, 2021.; Credit: DANIEL LEAL-OLIVAS/AFP via Getty Images

In our continuing series looking at the latest medical research and news on COVID-19, Larry Mantle speaks with Professor Kristen Choi of UCLA. 

Topics today include:

• Biden to announce new efforts on vaccination campaign as Delta variant spreads

• Hospitalization rates getting worse for black residents of L.A. County 

• Which parts of the U.S. could be breeding grounds for variants?

• New Israeli data about effectiveness of Pfizer against Delta variant

• England to lift mask restrictions

• Cases on rise in immigration detention centers in the U.S. 

• Bay area zoo is vaccinating big cats and some other animals 

Guest:

Kristen R. Choi, professor of nursing and public health at UCLA; registered nurse practicing at Gateways Hospital, based in Echo Park

This content is from Southern California Public Radio. View the original story at SCPR.org.

A waitress wears a face mask while serving at Langer's Delicatessen-Restaurant in Los Angeles on June 15.; Credit: Frederic J. Brown/AFP via Getty Images

Normal is not easily defined.

The past 15 months, though, have certainly been anything but.

Americans are starting to believe a "sense of normal" is approaching fairly soon, however, according to a new NPR/PBS NewsHour/Marist survey. The poll also found that with the coronavirus receding in this country, mask-wearing is declining and Americans are going out more. But they remain cautious about being in large crowds.

As the country continues to open up, more focus turns to the economy, which cratered during the beginning of the pandemic last year. And Americans are split by race, gender and politics on whether President Biden's ambitious policies are helping or not.

Race, gender, party divides on Biden and the economy

Three months ago, in a similar survey, 49% of adults said the president's policies were strengthening the economy, while 44% said they were weakening it.

Now, that's declined a net of 6 points, as 44% of respondents in the new poll say Biden's policies have strengthened the economy and 45% say the opposite. The percentage who were unsure also jumped 4 points. It's all a little bit of a warning sign for Biden, as he pushes for two large — and expensive — spending packages.

There are significant splits by race and gender:

• Just 39% of whites said Biden's policies have strengthened the economy, but 52% of people of color say they have.
• 54% of independent men say his policies have weakened the economy, while 56% of independent women say they've strengthened it. 
• 45% of white male college grads say Biden has strengthened the economy, but a significantly higher 64% of white women with college degrees said so.

Inflation vs. wages by party

A quarter of Americans rank inflation as the U.S. economy's top concern. That's followed by wages, unemployment, housing costs, labor shortages, gas prices and interest rates.

But there's a sharp political divide on the question. Republicans and independents rank inflation as their top concern, while for Democrats, it was wages. Just 4% of Republicans said wages were their top concern.

Return to "normal"

Americans are growing increasingly optimistic about when life will return to a "sense of normal," as the survey labels it.

In April, three-quarters of Americans said they believe it will take six months or more. Now, it's just half. About a quarter (27%) say it will be less than six months, up from 15% two months ago.

People are also growing more comfortable doing certain things, saying they're:

• dining out at restaurants (78%) and 
• visiting unvaccinated friends and family (75%).

But they are not as comfortable doing others:

• almost 7-in-10 are not going out to bars; 
• about two-thirds are not attending live concerts or sporting events (65%);
• and a majority have also not resumed going to in-person religious services (54%).

COVID-19 vaccines and going back to work

While half say they are concerned about another coronavirus surge, almost 9-in-10 U.S. adults with jobs say they are at least somewhat comfortable returning to work.

Notably, a majority (57%) of those with jobs do not believe employers should require COVID-19 vaccines as a condition to return to in-person work.

More than a quarter of Americans say they will not get vaccinated. The most resistant to getting vaccinated continue to be supporters of former President Donald Trump. Half of them say they won't get the shot, the highest of any group surveyed. Trump has touted the vaccine and got it himself.

Since Centers for Disease Control and Prevention guidelines came out, noting that Americans who have been vaccinated can largely set masks aside, there's been a double-digit decline in those saying they wear a mask even when it's not required.

There's also been a double-digit increase in those saying they generally do not wear a mask. In May, 49% said they wore masks even when it was not required. Now, that's just 36%.

One-in-five said they generally do not wear masks. Two months ago, it was less than one-in-10.

Affordability, not coronavirus, limiting vacations

Speaking of getting back to normal, a majority of Americans say they plan to take a vacation this summer.

But of the significant minority (45%) who say they aren't taking one, almost three times as many cited affordability (35%) as the main reason for not going, as opposed to concerns about COVID-19 (12%).

Methodology: The poll of 1,115 U.S. adults was conducted using live telephone interviewers from June 22 through June 29. Survey questions were available in English or Spanish. The full sample has a margin of error of plus or minus 3.7 percentage points, with larger margins of error for smaller group subsets.

This content is from Southern California Public Radio. View the original story at SCPR.org.

The National Academies stand ready to convene America’s best minds in research, government, medicine, and private industry to marshal evidence-based insights and advice for confronting today’s pandemic and future crises.

In light of the present situation in the U.S., we believe that it is essential to explore a wide range of options for treating the increasing numbers of very ill patients with COVID-19 respiratory illness.